Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study

OBJECTIVES: To assess the efficacy and safety of vonoprazan on heartburn symptoms in patients with nonerosive reflux disease (NERD) (ClinicalTrials.gov: NCT02954848). METHODS: This phase 3, double-blind, placebo-controlled study included Japanese patients aged 20 years and older with grade N/M NERD...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Transl Gastroenterol
Glavni autori: Kinoshita, Yoshikazu, Sakurai, Yuuichi, Takabayashi, Nobuyoshi, Kudou, Kentaro, Araki, Takahiro, Miyagi, Takuya, Iwakiri, Katsuhiko, Ashida, Kiyoshi
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6890278/
https://ncbi.nlm.nih.gov/pubmed/31770139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ctg.0000000000000101
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items